Aladdin Scientific
Garivulimab (anti-PD-L1) (C007B-552784)
Garivulimab (anti-PD-L1) is a humanized IgG1-variant monoclonal antibody that specifically targets and binds to PD-L1. Garivulimab (anti-PD-L1) selectively blocks the interaction of PD-L1 and PD-1.
Description
Garivulimab (anti-PD-L1) is a humanized IgG1-variant monoclonal antibody that specifically targets and binds to PD-L1. Garivulimab (anti-PD-L1) selectively blocks the interaction of PD-L1 and PD-1. Garivulimab (anti-PD-L1) has antitumor activity.Purity>95% (SDS-PAGE&SEC)Endotoxin Level< 1.0EU/mg
Specification: ExactAb™, Validated, Carrier Free, Low Endotoxin, Azide Free, Recombinant, ≥95%(SDS-PAGE&SEC), Lot by Lot
Related Documents: https://ald-pub-files.oss-cn-shanghai.aliyuncs.com/aladdinsci/pdp/sds/1/AB182922-SCI_2719e9b408c6b752ae008767cf098e19.pdf
Specifications
- UPC:
- 51111637
- Condition:
- New
- Weight:
- 0.07 Ounces
- HazmatClass:
- No
- Quantity:
- 1
- Unit of Measurement:
- EA
- WeightUOM:
- LB
- MPN:
- Ab182922-10mg
- CAS:
- 2342597-81-1
- Product Size:
- 10mg
-
Fast shipping — 3-day lead time
-
Guaranteed quality & reliable delivery
-
Shipping Lead-Time: 4-8 weeks
